DIRECTOR SHARE OPTIONS

RNS Number : 2048O
Benchmark Holdings PLC
28 January 2019
 

28 January 2019

 

BENCHMARK HOLDINGS PLC
("Benchmark" or the "Company")

DIRECTOR SHARE OPTIONS 

Benchmark Holdings plc announces that on 25 January 2019, and in accordance with the intention disclosed in its Annual Report and Accounts published on 24 January 2019, options over Ordinary Shares of 0.1 pence each ("Ordinary Shares") were granted to Malcolm Pye, Chief Executive Officer; Mark Plampin, Chief Financial Officer; and Alex Raeber, Chief Scientific Officer under the Company Share Option Plan (CSOP). 

Options over a total of 555,100 Ordinary Shares were granted to Malcolm Pye; options over a total of 447,600 Ordinary Shares were granted to Mark Plampin; and options over a total of 400,000 Ordinary Shares were granted to Alex Raeber.  Following this grant, Malcolm Pye remains interested in 15,145,686 Ordinary Shares and holds options over a total of 1,055,100 Ordinary Shares in the Company, representing approximately 2.90% and 0.19% of Benchmark's existing issued share capital respectively.  Mark Plampin remains interested in 536,686 Ordinary Shares and holds options over a total of 972,185 Ordinary Shares in the Company, representing approximately 0.10% and 0.17% of Benchmark's existing issued share capital respectively.  Alex Raeber remains interested in 100,000 Ordinary Shares and holds options over a total of 400,000 Ordinary Shares in the Company, representing approximately 0.02% and 0.07% of Benchmark's existing issued share capital respectively.

The options granted have a vesting period of three years, may be exercised up to the tenth anniversary of grant, have an exercise price of 58.5 pence per Ordinary Share, and are not subject to performance criteria.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities: 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Malcolm Pye

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director 

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares


ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

58.5 pence

555,100

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 555,100

Price: Nil

e) 

 

Date of the transaction 

 

25 January 2019

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Mark Plampin 

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director 

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares


ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

58.5 pence

447,600

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 447,600

Price: Nil

e) 

 

Date of the transaction 

 

25 January 2019

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Alex Raeber 

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director 

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares


ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

58.5 pence

400,000

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 400,000

Price: Nil

e) 

 

Date of the transaction 

 

25 January 2019

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

 

Enquiries

Benchmark Holdings plc

                      Tel: 020 3915 1236

Malcolm Pye, CEO


Ivonne Cantu, Investor Relations Director


Rachel Aninakwah, Communications




Numis

                      Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)


James Black (Corporate Broking)




MHP


Katie Hunt / Reg Hoare /Alistair de Kare-Silver     

                  Tel: 020 3128 8742                                 

                      benchmark@mhpc.com



 

Notes to Editors:

Benchmark's mission is to drive sustainability in food production.

We are a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, health and welfare. Our main products are salmon eggs with superior genetic traits, specialist nutrition products for shrimp and fish, and health treatments including a sea lice treatment for salmon. We serve all the major aquaculture markets around the world and have leading market positions. Benchmark operates in 27 countries, employs 1,066 people and reported revenues of £140m in 2017.

For further information on Benchmark please visit www.benchmarkplc.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBUURKAAAUUR
UK 100

Latest directors dealings